TomoTissue is at the forefront of revolutionizing biomedical research and (pre)clinical diagnostics through its pioneering 3D X-ray based histology services. By leveraging our extensive expertise in microfocus X-ray
computed tomography (XCT) and contrast-enhanced XCT (CECT) imaging, we provide a non-destructive and highly detailed examination of biomaterials and biological tissues, a technique we refer to as 3D X-ray based histology. Unlike
conventional contrast-enhancing staining agents (CESAs), our in-house synthesized agents have demonstrated exceptional preservation of tissue integrity. Our mission is to deliver proprietary CESAs, and high-quality 3D imaging data
and data analysis, catering to the diverse needs of commercial and academic research institutes, (pre)clinical pathology laboratories, as well as pharmaceutical and biotechnology companies.